Circulating tumor cell clusters: What we know and what we expect (Review)

The major cause of cancer-associated mortality is tumor metastasis, a disease that is far from understood. Many studies have observed circulating tumor cells (CTCs) in patients' circulation systems, and a few latest investigations showed that CTC clusters have a potentially high capacity of metastasis. The capture and analysis of CTC clusters offer new insights into tumor metastasis and can facilitate the development of cancer treatments. We reviewed the research history of the CTC clusters, as well as the technologies used for detecting and isolating CTC clusters. In addition, we discuss the characteristics of CTC clusters and their roles in tumor dissemination. Clinical relevance of CTC clusters was also implicated in currently limited data. Moving forward, the next frontier in this field is to develop more efficient capture methods and decipher conundrums of characterization of CTC clusters. This will ultimately identify the clinical value of CTC clusters as a biomarker and therapeutic target.

[1]  John W. Park,et al.  Circulating Tumor Cells , 2017, Methods in Molecular Biology.

[2]  P. Bendahl,et al.  Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort , 2016, BMC Cancer.

[3]  Mehmet Toner,et al.  Clusters of circulating tumor cells traverse capillary-sized vessels , 2016, Proceedings of the National Academy of Sciences.

[4]  E. Gilson,et al.  High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness , 2016, Cancer medicine.

[5]  D. Beer,et al.  Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer. , 2016, The Journal of thoracic and cardiovascular surgery.

[6]  Y. Jeng,et al.  Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma. , 2016, Clinical chemistry.

[7]  James E. Verdone,et al.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters , 2016, Proceedings of the National Academy of Sciences.

[8]  Hushan Yang,et al.  Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer , 2015, Breast Cancer Research and Treatment.

[9]  R. Datar,et al.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.

[10]  Pilhan Kim,et al.  Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells. , 2015, Cancer research.

[11]  B. Stanger,et al.  Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. , 2015, Cancer discovery.

[12]  Shuang Hou,et al.  Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases , 2015, Cancer.

[13]  Linda Li,et al.  Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells , 2015, Oncotarget.

[14]  Aufried T. M. Lenferink,et al.  The detection of EpCAM+ and EpCAM– circulating tumor cells , 2015, Scientific Reports.

[15]  A. A. Modestov,et al.  Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  Peter Kuhn,et al.  A physical sciences network characterization of circulating tumor cell aggregate transport. , 2015, American journal of physiology. Cell physiology.

[17]  Sridhar Ramaswamy,et al.  A microfluidic device for label-free, physical capture of circulating tumor cell-clusters , 2015, Nature Methods.

[18]  I. Karádi,et al.  Metastasis blood test by flow cytometry: In vivo cancer spheroids and the role of hypoxia , 2015, International journal of cancer.

[19]  Donghong Zhang,et al.  Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer , 2015, International journal of cancer.

[20]  O. McCarty,et al.  The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation. , 2015, American journal of physiology. Cell physiology.

[21]  A. Sieuwerts,et al.  Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer. , 2015, Cancer letters.

[22]  M. Mascalchi,et al.  Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC , 2015, Journal of Cancer Research and Clinical Oncology.

[23]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[24]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[25]  C. Holmes,et al.  Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer , 2014, Journal of cellular physiology.

[26]  C. Nelson,et al.  Circulating tumor cell detection in high-risk non-metastatic prostate cancer , 2014, Journal of Cancer Research and Clinical Oncology.

[27]  V. Weinberg,et al.  Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration‐resistant prostate cancer , 2014, International journal of cancer.

[28]  Caroline Dive,et al.  Molecular analysis of circulating tumour cells—biology and biomarkers , 2014, Nature Reviews Clinical Oncology.

[29]  E. Lianidou.  Circulating tumor cell isolation: a marathon race worth running. , 2014, Clinical chemistry.

[30]  Ming-Da Zhou,et al.  Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells. , 2014, Clinical chemistry.

[31]  C. Lim,et al.  Isolation and retrieval of circulating tumor cells using centrifugal forces , 2013, Scientific Reports.

[32]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[33]  M. King,et al.  Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion , 2013, PloS one.

[34]  T. Teknos,et al.  Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck , 2012, PloS one.

[35]  Caroline Dive,et al.  Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  J. Nieva,et al.  Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology , 2012, Physical biology.

[37]  Peter Kuhn,et al.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors , 2012, Physical biology.

[38]  Caroline Dive,et al.  Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[39]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[40]  Meenakshi Upreti,et al.  Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics. , 2011, Translational oncology.

[41]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[42]  Richard O Hynes,et al.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.

[43]  Caroline Dive,et al.  Circulating tumor cells as a window on metastasis biology in lung cancer. , 2011, The American journal of pathology.

[44]  Dai Fukumura,et al.  Malignant cells facilitate lung metastasis by bringing their own soil , 2010, Proceedings of the National Academy of Sciences.

[45]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[46]  J. Rhodes,et al.  Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis , 2010, Molecular Cancer.

[47]  G. Driesel,et al.  Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate‐specific antigen levels of 4–10 ng/mL and disease prognostication after radical prostatectomy , 2010, BJU international.

[48]  Jason P. Gleghorn,et al.  Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. , 2010, Lab on a chip.

[49]  James N Turner,et al.  Isolation of tumor cells using size and deformation. , 2009, Journal of chromatography. A.

[50]  J. A. van der Laak,et al.  Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma , 2009, The Journal of pathology.

[51]  J. Rhodes,et al.  Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. , 2009, Cancer research.

[52]  Weihong Tan,et al.  Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. , 2009, Analytical chemistry.

[53]  Swee Jin Tan,et al.  Microdevice for the isolation and enumeration of cancer cells from blood , 2009, Biomedical microdevices.

[54]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[55]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[56]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  Paul I. Okagbare,et al.  Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. , 2008, Journal of the American Chemical Society.

[58]  B. Molnár,et al.  Elevation in Peripheral Blood Circulating Tumor Cell Number Correlates with Macroscopic Progression in UICC Stage IV Colorectal Cancer Patients , 2008, Disease markers.

[59]  Shahin Rafii,et al.  Migratory neighbors and distant invaders: tumor-associated niche cells. , 2008, Genes & development.

[60]  Siyang Zheng,et al.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. , 2007, Journal of chromatography. A.

[61]  P. Wesseling,et al.  Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis , 2007, Oncogene.

[62]  J. Hirabayashi,et al.  Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.

[63]  A. Varki,et al.  L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. , 2006, Cancer research.

[64]  M.,et al.  Relationship between Size and Distribution of “Spontaneous†• Metastases and Three Sizes of Intravenously Injected Particles of VX 2 Carcinoma , 2006 .

[65]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[66]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[67]  Bernard Lacour,et al.  Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer , 2004, Hepatology.

[68]  K. Pienta,et al.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.

[69]  T. Roskams,et al.  Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study. , 2003, The Journal of surgical research.

[70]  T. Sugino,et al.  An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. , 2002, The American journal of pathology.

[71]  Ajit Varki,et al.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Molnár,et al.  Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  A W Partin,et al.  Identification and characterization of circulating prostate carcinoma cells , 2000, Cancer.

[74]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[75]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[76]  G. Assmann,et al.  Isolation of prostate-derived single cells and cell clusters from human peripheral blood. , 1996, Cancer research.

[77]  J E Talmadge,et al.  Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. , 1986, Cancer research.

[78]  D. Glaves.  Correlation between circulating cancer cells and incidence of metastases. , 1983, British Journal of Cancer.

[79]  H. Bosmann,et al.  Quantitative relationship between volume of tumour cell units and their intravascular survival. , 1978, British Journal of Cancer.

[80]  L. Liotta,et al.  The significance of hematogenous tumor cell clumps in the metastatic process. , 1976, Cancer research.

[81]  The Colony Forming Efficiency of Single Cells and Cell Aggregates from a Spontaneous Mouse Mammary Tumour Using the Lung Colony Assay , 1974, British Journal of Cancer.

[82]  H. Bingham.  Immune stimulationinhibition of experimental cancer metastasis , 1974 .

[83]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[84]  I. Fidler,et al.  Immune stimulation-inhibition of experimental cancer metastasis. , 1974, Cancer research.

[85]  N. Galanti,et al.  Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease , 1973, International journal of cancer.

[86]  I. Fidler.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. , 1973, European journal of cancer.

[87]  A. Matheson,et al.  The effect of intravenous fluids on the development on experimental tumour metastases: their effect on tumour cell aggregation. , 1966, British Journal of Cancer.

[88]  M. Mahaley,et al.  Relationship between size and distribution of spontaneous metastases and three sizes of intravenously injected particles of VX2 carcinoma. , 1958, Cancer research.

[89]  S WATANABE,et al.  The metastasizability of tumor cells , 1954, Cancer.